Simplify Asset Management Inc. Lowers Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Simplify Asset Management Inc. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.3% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 39,260 shares of the company’s stock after selling 14,768 shares during the period. Simplify Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $2,795,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Western Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 2.4% in the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after acquiring an additional 125 shares during the last quarter. United Community Bank raised its position in shares of GE HealthCare Technologies by 10.2% in the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in GE HealthCare Technologies by 3.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after purchasing an additional 134 shares in the last quarter. Thoma Capital Management LLC boosted its stake in GE HealthCare Technologies by 1.4% in the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its position in GE HealthCare Technologies by 1.1% during the 4th quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock valued at $1,030,000 after purchasing an additional 140 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $65.57 on Friday. The company has a market cap of $29.83 billion, a price-to-earnings ratio of 15.69, a price-to-earnings-growth ratio of 1.78 and a beta of 0.72. The company’s 50 day moving average is $63.70 and its 200 day moving average is $73.29. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.35%.

Insider Buying and Selling

In other news, Director Kevin Lobo bought 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. The trade was a 229.20% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Frank R. Jimenez acquired 1,750 shares of GE HealthCare Technologies stock in a transaction dated Thursday, April 30th. The stock was purchased at an average cost of $60.45 per share, with a total value of $105,787.50. Following the completion of the purchase, the insider owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 21,847 shares of company stock worth $1,361,355 in the last quarter. Company insiders own 0.36% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on GEHC. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Mizuho cut their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Barclays reduced their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Finally, Citigroup lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $80.20.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.